Senior medical support for medtech and medical-device companies
For medtech and medical-device companies, the relevant starting point depends on whether the need concerns medical ownership, clinical evidence, Medical Affairs, independent review or a board or investor decision.
Gisselbaek Consulting supports medtech and medical-device companies where product value depends on clinical evidence, adoption logic, medical credibility and execution discipline. The work connects clinical need, evidence generation, stakeholder trust and commercial readiness.
Choose the relevant starting point
- Fractional Senior Medical Leadership when continuing senior medical ownership and cross-functional accountability are needed.
- Clinical Development Strategy / Investable Clinical Programme for clinical evidence strategy, study concepts, endpoints and the next decision the evidence must support.
- Medical Affairs Strategy when scientific engagement, stakeholder insight, adoption readiness or the medical operating model needs strengthening.
- Senior Medical Review for independent challenge of high-stakes scientific, investor, partner or market-facing content.
- Investor & Board Due Diligence when an investment, partnering, portfolio or board decision depends on the credibility of the clinical and medical case.
If the most relevant route is still unclear, use the Service Navigator to identify a practical starting point.
Contact Gisselbaek Consulting to discuss the medical, clinical or organisational decision in front of you.